Pregabalin Extended-Release Tablets

pregabalin Pregabalin Milpharm is indicated for the treatment of peripheral and central neuropathic pain in adults Epilepsy Pregabalin Milpharm is indicated as

and pregabalin as Schedule 3 Controlled Drugs from 1 April 2019 Background In January 2016, the Advisory Committee for the Misuse of Drugs pregabalin Pregabalin Sandoz contains the active ingredient pregabalin Pregabalin Sandoz is used to treat neuropathic pain, which is caused by an abnormality of, or